CaptureSelect™ Biotin Anti-FVII Conjugate consists of a 13 kDa camelid antibody fragment (affinity ligand) that specifically binds with high affinity and selectivity to both recombinant and plasma-derived human factor VII as well as its activated form (FVIIa). The affinity ligand is chemically conjugated to biotin via an appropriate spacer that retains the binding reactivity of the ligand when used in combination with streptavidin-based conjugates or streptavidin pre-coated surfaces. This conjugate allows you to detect, quantitate, and characterize recombinant and plasma-derived human FVII.
Applications for CaptureSelect Biotin Anti-FVII Conjugate include ELISA, Gyrolab™-based immunoassays, and label-free detection platforms such as those based on surface plasmon resonance (Biacore™ and IBIS-MX96 systems) and bio-layer interferometry (ForteBio™ Octet™ systems).
For Research Use Only. Not for use in diagnostic procedures.